Spain · AEMPS CIMA
valsartán + indapamida
Source ingredient · 2 source records
Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.
VALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
COMPRIMIDO DE LIBERACIÓN MODIFICADA / Krka D.D. Novo Mesto, Krka Farmaceutica S.L.
VALOMINDO 80 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
COMPRIMIDO DE LIBERACIÓN MODIFICADA / Krka D.D. Novo Mesto, Krka Farmaceutica S.L.